Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Alzheimer's disease is the public health crisis of the 21st century. There is a clear need for a widely available, inexpensive and reliable method to diagnosis Alzheimer's disease in the earliest stages, track disease progression, and accelerate clinical development of new therapeutics. One avenue of research being explored is blood based biomarkers. In April 2012, the Alzheimer's Association and the Alzheimer's Drug Discovery Foundation convened top scientists from around the world to discuss the state of blood based biomarker development. This manuscript summarizes the meeting and the resultant discussion, including potential next steps to move this area of research forward.

Original publication

DOI

10.1016/j.jalz.2013.10.007

Type

Journal article

Journal

Alzheimers Dement

Publication Date

01/2014

Volume

10

Pages

109 - 114

Keywords

Alzheimer's disease, Biomarker, Blood based biomarker, Diagnostics, Early detection, Early diagnosis, Alzheimer Disease, Biomarkers, Disease Progression, Early Diagnosis, Enzyme-Linked Immunosorbent Assay, Humans